System and method for monitoring nitric oxide levels using a non-invasive, multi-band biosensor
A device includes an optical circuit that obtains a first signal at a first wavelength using light reflected from skin tissue of a patient, wherein the first wavelength has a high absorption coefficient for nitric oxide (NO) in blood flow and a second PPG signal at a second wavelength using light reflected from skin tissue of the patient, wherein the second wavelength has a low absorption coefficient for NO in blood flow. A measurement of a level of NO in blood flow is determined using the first PPG signal and the second PPG signal. A health condition is determined using the measurement of the level of NO, such as hyperglycemia or hypoglycemia.
1. A device, comprising:
an optical circuit including a light source and a photodetector, the optical circuit configured to:
emit light using the light source at each of a first wavelength having a high absorption coefficient for nitric oxide (NO) in blood flow and a second wavelength having a low absorption coefficient for NO in blood flow;
measure reflections of the light emitted by the light source from skin tissue of a patient to obtain each of a first photoplethysmography (PPG) signal corresponding to reflected light at the first wavelength and a second PPG signal corresponding to reflected light at the second wavelength; and
at least one processing circuit configured to:
determine a measurement using the first PPG signal and the second PPG signal, the measurement corresponding to an indication for hyperglycemia or hypoglycemia;
compare the measurement to a predetermined normal range for the measurement; and
determine whether the measurement is outside of the predetermined normal range.
2. The device of claim 1 , wherein the measurement includes an AC component of the first PPG signal.
3. The device of claim 1 , wherein the measurement includes a ratio of an AC component of the first PPG signal and an AC component of the second PPG signal.
4. The device of claim 1 , wherein the measurement includes a level of NO in the blood flow of the patient.
5. The device of claim 1 , wherein the measurement includes a level of glucose in the blood flow of the patient.
6. The device of claim 1 , wherein the optical circuit is configured on a patch, wrist band, finger attachment or ear piece.
7. The device of claim 1 , wherein the optical circuit and the at least one processing circuit is configured on a patch, wrist band or ear piece.
8. The device of claim 1 , wherein the at least one processing circuit is further configured to generate an alert in response to the measurement being outside of the predetermined normal range.
9. A device, comprising:
an optical circuit including a light source and a photodetector, the optical circuit configured to:
emit light using the light source at each of a first wavelength having a high absorption coefficient for nitric oxide (NO) in blood flow and a second wavelength having a low absorption coefficient for NO in blood flow;
measure reflections of the light emitted by the light source from skin tissue of a patient to obtain each of a first photoplethysmography (PPG) signal corresponding to reflected light at the first wavelength and a second PPG signal corresponding to reflected light at the second wavelength; and
at least one processing circuit configured to:
determine a measurement of a level of NO in blood flow using the first PPG signal and the second PPG signal;
compare the measurement of the level of NO to a predetermined normal range for NO for a health condition; and
determine the measurement of the level of NO is outside of the predetermined normal range.
10. The device of claim 9 , wherein the processing circuit is configured to generate an alert when the measurement of the level of NO is outside of the predetermined normal range.
11. The device of claim 9 , wherein the processing circuit is configured to generate a display of the measurement of the level of NO.
12. The device of claim 9 , wherein the measurement of the level of NO includes an AC component of the first PPG signal.
13. The device of claim 9 , wherein the measurement of the level of NO includes a ratio of an AC component of the first PPG signal and an AC component of the second PPG signal.
14. The device of claim 9 , wherein the health condition includes one or more of:
hyperglycemia, hypoglycemia, diabetic condition, insulin response, hypovolemia, vascular health, dementia, Alzheimer's disease, post-traumatic stress syndrome (PTSD), infection or sepsis.
15. The device of claim 9 , wherein the health condition includes a presence of one or more compounds that lead to unsafe levels of NO in blood vessels, wherein the one or more compounds include one or more of: lidocaine, nitrates such as nitroglycerin, nitric oxide, nitrogen based fertilizers, dapsone, benzocaine, cyanide, or anesthesia.
16. The device of claim 9 , further comprising a transceiver configured to transmit data to a remote user device.
17. The device of claim 9 , wherein the first wavelength having a high absorption coefficient for NO in blood flow is in a range of approximately 380 nm to 400 nm.
18. A device, comprising:
at least one processing circuit configured to:
obtain a plurality of PPG signals from at least one photodetector circuit, the plurality of PPG signals including:
a first PPG signal corresponding to a first wavelength of light reflected from skin tissue of a patient, wherein the first wavelength has a high absorption coefficient for nitric oxide (NO) in blood flow; and
a second PPG signal corresponding to a second wavelength of light reflected from skin tissue of the patient, wherein the second wavelength has a low absorption coefficient for NO in blood flow;
determine a measurement of a level of NO in blood flow using the first PPG signal and the second PPG signal;
compare the measurement of the level of NO to a predetermined normal range for NO for a health condition; and
determine the measurement of the level of NO is outside of the predetermined normal range.